Now Is A Suitable Moment For A Long-Term Purchase Of Trevi Therapeutics Inc (NASDAQ: TRVI)
Currently, there are 75.45M common shares owned by the public and among those 52.99M shares have been available to trade. The company’s stock has a 5-day price change of -11.33% and 29.55% over the past three months. TRVI shares are trading 197.76% year to date (YTD), with the 12-month market performance up to 187.05% higher. […]
Is Trevi Therapeutics Inc (NASDAQ: TRVI) Proving The Doubters Wrong?
Trevi Therapeutics Inc (TRVI) concluded trading on Thursday at a closing price of $3.60, with 63.75 million shares of worth about $229.5 million changed hands on the day. Half year performance of the stock remained positive as price took a surge of 29.96% during that period and on December 12, 2024 the price saw a […]
